Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 78,300 shares, a growth of 131.0% from the February 13th total of 33,900 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is currently 17.0 days. Approximately 0.1% of the company’s shares are sold short.

Oxford Biomedica Price Performance

Shares of OTCMKTS:OXBDF opened at $3.53 on Friday. The company has a 50-day moving average price of $4.79 and a 200-day moving average price of $4.97. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a 12 month low of $2.40 and a 12 month high of $5.68.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.